Title: A Phase IV, Open-label, Single-Center Study on the Effects of a Nutritional Supplement
Combination on Body Weight Management over a 90-day period
: Nutritional supplement and protein shakes
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01725958
Ages eligible for Study
25 Years to 65 Years
Genders eligible for Study
Accepts Healthy Volunteers
Females and Males aged 25-65 years
Signed informed consent
BMI between 25 and 40 kg/m2
A resting normotensive blood pressure is defined as a systolic blood pressure between 90-145 mmHg and a diastolic blood pressure of 50 90 mmHg
Use of effective method of contraception by females of childbearing [potential and agreement to continue to practice an acceptable method of contraception for the duration of their participation in the study]. Acceptable methods of contraception include oral, injectable, or implantable contraceptives; intrauterine devices, diaphragm plus spermicide; abstinence (must agree to use double-barrier method if they become sexually active), transdermal patch, or any double barrier method including a vasectomized sexual partner. Women who have had a hysterectomy or tubal ligation at least 6 months prior to Visit 1 or who have been post-menopausal
Ability to speak and understand English
Willing to fast the morning of visit where blood samples are taken
Self-reported chronic condition that may affect subject safety (e.g., diabetes, cardiovascular disease) or significantly impact product effectiveness (e.g., chronic fatigue)
Pregnancy/suspected pregnancy, breastfeeding or planning to become pregnant during the course of the study.
Use of Antihypertensive medication for less than 4 months or unregulated clinically blood pressure.
Having undergone gastroplasty or bariatric surgery in the past 10 years.
Taking medication (e.g., thyroid medication), must be stable for at least four months.
Allergies to any ingredients contained in the Nutritional Supplement.
Medical treatment for insomnia or depression within 30-days prior to the screening visit.
Tobacco (e.g. cigarettes, chewing tobacco, pipe, nicotine patches) use within 30-days prior to the screening visit.
Planned surgical procedure during the course of the study.
Currently participating in another study or have done so within 30 days prior to the screening visit or is likely to enroll in another clinical or nutritional study.
Currently taking any medication or supplement for the use of weight loss must be discontinued prior to Visit 1 Baseline Day 0.
Currently participating in a weight loss program or participated in a weight loss program in the past 6 months.
All locations for NCT01725958
United States (1)
Aspen Clinical Research
Orem, Utah, United States, 84058
View full eligibility
Tris trial is registered with FDA with number: NCT01725958. The sponsor of the trial is Pharmanex and it is looking for 60 volunteers for the current phase.
Official trial title: A Phase IV, Open-label, Parallel Group, Single-Center Study on the Effects of a Nutritional Supplement Combination on Body Weight Management Over a 90-day Period
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.